349
Views
5
CrossRef citations to date
0
Altmetric
Review Articles

Metabolism of the areca alkaloids – toxic and psychoactive constituents of the areca (betel) nut

Pages 343-360 | Received 07 Jan 2022, Accepted 27 Apr 2022, Published online: 29 May 2022

References

  • Allocati N, Masulli M, Di Ilio C, Federici L. 2018. Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases. Oncogenesis. 7(1):8.
  • Andrews P. 1997. Cocaethylene toxicity. J Addict Dis. 16(3):75–84.
  • Asthana S, Greig NH, Holloway HW, Raffaele KC, Berardi A, Schapiro MB, Rapoport SI, Soncrant TT. 1996. Clinical pharmacokinetics of arecoline in subjects with Alzheimer’s disease. Clin Pharmacol Ther. 60(3):276–282.
  • Atack JR, Yu QS, Soncrant TT, Brossi A, Rapoport SI. 1989. Comparative inhibitory effects of various physostigmine analogs against acetyl- and butyrylcholinesterases. J Pharmacol Exp Ther. 249(1):194–202.
  • Bales A, Peterson MJ, Ojha S, Upadhaya K, Adhikari B, Barrett B. 2009. Associations between betel nut (Areca catechu) and symptoms of schizophrenia among patients in Nepal: a longitudinal study. Psychiatry Res. 169(3):203–211.
  • Bissessur S, Naidoo S. 2009. Areca nut and tobacco chewing habits in Durban, KwaZulu Natal. SADJ. 64(10):460–463.
  • Boucher BJ, Mannan N. 2002. Metabolic effects of the consumption of Areca catechu. Addict Biol. 7(1):103–110.
  • Bourland JA, Martin DK, Mayersohn M. 1997. Carboxylesterase-mediated transesterification of meperidine (Demerol) and methylphenidate (Ritalin) in the presence of [2H6]ethanol: preliminary in vitro findings using a rat liver preparation. J Pharm Sci. 86(12):1494–1496.
  • Boyland E, Nery R. 1969. Mercapturic acid formation during the metabolism of arecoline and arecaidine in the rat. Biochem J. 113(1):123–130.
  • Calmels S, Ohshima H, Henry Y, Bartsch H. 1996. Characterization of bacterial cytochrome cd(1)-nitrite reductase as one enzyme responsible for catalysis of nitrosation of secondary amines. Carcinogenesis. 17(3):533–536.
  • Chandra JN, Malviya M, Sadashiva CT, Subhash MN, Rangappa KS. 2008. Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models. Neurochem Int. 52(3):376–383.
  • Chandra PS, Mulla U. 2007. Areca nut: the hidden Indian ‘gateway’ to future tobacco use and oral cancers among youth. Indian J Med Sci. 61(6):319–321.
  • Chang MC, Ho YS, Lee PH, Chan CP, Lee JJ, Hahn LJ, Wang YJ, Jeng JH. 2001. Areca nut extract and arecoline induced the cell cycle arrest but not apoptosis of cultured oral KB epithelial cells: association of glutathione, reactive oxygen species and mitochondrial membrane potential. Carcinogenesis. 22(9):1527–1535.
  • Chang MC, Lin LD, Wu HL, Ho YS, Hsien HC, Wang TM, Jeng PY, Cheng RH, Hahn LJ, Jeng JH. 2013. Areca nut-induced buccal mucosa fibroblast contraction and its signaling: a potential role in oral submucous fibrosis-a precancer condition. Carcinogenesis. 34(5):1096–1104.
  • Chang PY, Kuo TM, Chen PK, Lin YZ, Hua CH, Chen YC, Ko YC. 2017. Arecoline N-oxide upregulates caspase-8 expression in oral hyperplastic lesions of mice. J Agric Food Chem. 65(47):10197–10205.
  • Chang YC, Hu CC, Lii CK, Tai KW, Yang SH, Chou MY. 2001. Cytotoxicity and arecoline mechanisms in human gingival fibroblasts in vitro. Clin Oral Investig. 5(1):51–56.
  • Chang YC, Hu CC, Tseng TH, Tai KW, Lii CK, Chou MY. 2001. Synergistic effects of nicotine on arecoline-induced cytotoxicity in human buccal mucosal fibroblasts. J Oral Pathol Med. 30(8):458–464.
  • Chang YC, Lii CK, Tai KW, Chou MY. 2001. Adverse effects of arecoline and nicotine on human periodontal ligament fibroblasts in vitro. J Clin Periodontol. 28(3):277–282.
  • Changrani J, Gany FM, Cruz G, Kerr R, Katz R. 2006. Paan and gutka use in the United States: a pilot study in Bangladeshi and Indian-Gujarati immigrants in New York City. J Immigr Refug Stud. 4(1):99–110.
  • Chen WY, Lee CY, Lin PY, Hsieh CE, Ko CJ, Lin KH, Lin CC, Ming YZ, Chen YL. 2017. Betel nut chewing is associated with reduced tacrolimus concentration in Taiwanese liver transplant recipients. Transplant Proc. 49(2):326–329.
  • Chen X, He Y, Deng Y. 2021. Chemical composition, pharmacological, and toxicological effects of betel nut. Evid Based Complement Alternat Med. 2021:1808081.
  • Chou CH, Chuang LY, Tseng WL, Lu CY. 2012. Characterization of protein adducts formed by toxic alkaloids by nano-scale liquid chromatography with mass spectrometry. J Mass Spectrom. 47(10):1303–1312.
  • Chu NS. 2002. Neurological aspects of areca and betel chewing. Addict Biol. 7(1):111–114.
  • Cox S, Vickers ER, Ghu S, Zoellner H. 2010. Salivary arecoline levels during areca nut chewing in human volunteers. J Oral Pathol Med. 39(6):465–469.
  • Dasgupta R, Saha I, Pal S, Bhattacharyya A, Sa G, Nag TC, Das T, Maiti BR. 2006. Immunosuppression, hepatotoxicity and depression of antioxidant status by arecoline in albino mice. Toxicology. 227(1–2):94–104.
  • Deahl M. 1989. Betel nut-induced extrapyramidal syndrome: an unusual drug interaction. Mov Disord. 4(4):330–332.
  • Deb S, Chatterjee A. 1998. Influence of buthionine sulfoximine and reduced glutathione on arecoline-induced chromosomal damage and sister chromatid exchange in mouse bone marrow cells in vivo. Mutagenesis. 13(3):243–248.
  • Dirven HA, van Ommen B, van Bladeren PJ. 1996. Glutathione conjugation of alkylating cytostatic drugs with a nitrogen mustard group and the role of glutathione S-transferases. Chem Res Toxicol. 9(2):351–360.
  • Do ETT, Vu M. 2020. A qualitative study of gutka and paan masala use among Bhutanese and Burmese migrants in Georgia. PLoS One. 15(8):e0237266.
  • Feng Y, Wang H, Wang Q, Huang W, Peng Y, Zheng J. 2017. Chemical interaction of protein cysteine residues with reactive metabolites of methyleugenol. Chem Res Toxicol. 30(2):564–573.
  • Forbes LS. 1964. The use of arecoline hydrobromide in the treatment of taeniid infections in dogs. Ann Trop Med Parasitol. 58:116–118.
  • Franke AA, Li X, Lai JF. 2016. Pilot study of the pharmacokinetics of betel nut and betel quid biomarkers in saliva, urine, and hair of betel consumers. Drug Test Anal. 8(10):1095–1099.
  • French CE, Bruce NC. 1994. Purification and characterization of morphinone reductase from Pseudomonas putida M10. Biochem J. 301(1):97–103.
  • Furber S, Jackson J, Johnson K, Sukara R, Franco L. 2013. A qualitative study on tobacco smoking and betel quid use among Burmese refugees in Australia. J Immigr Minor Health. 15(6):1133–1136.
  • Garcia-Algar O, Vall O, Alameda F, Puig C, Pellegrini M, Pacifici R, Pichini S. 2005. Prenatal exposure to arecoline (areca nut alkaloid) and birth outcomes. Arch Dis Child Fetal Neonatal Ed. 90(3):F276–277.
  • Garg A, Chaturvedi P, Gupta PC. 2014. A review of the systemic adverse effects of areca nut or betel nut. Indian J Med Paediatr Oncol. 35(1):3–9.
  • Giri S, Idle JR, Chen C, Zabriskie TM, Krausz KW, Gonzalez FJ. 2006. A metabolomic approach to the metabolism of the areca nut alkaloids arecoline and arecaidine in the mouse. Chem Res Toxicol. 19(6):818–827.
  • Giri S, Krausz KW, Idle JR, Gonzalez FJ. 2007. The metabolomics of (+/-)-arecoline 1-oxide in the mouse and its formation by human flavin-containing monooxygenases. Biochem Pharmacol. 73(4):561–573.
  • Grubic Z, Sket D, Brzin M. 1988. Iso-OMPA-induced potentiation of soman toxicity in rat correlates with the inhibition of plasma carboxylesterases. Arch Toxicol. 62(5):398–399.
  • Guo SE, Huang TJ, Huang JC, Lin MS, Hong RM, Chang CH, Chen MY. 2013. Alcohol, betel-nut and cigarette consumption are negatively associated with health promoting behaviors in Taiwan: a cross-sectional study. BMC Public Health. 13:257.
  • Gupta PC, Ray CS. 2004. Epidemiology of betel quid usage. Ann Acad Med Singap. 33(4):31–36.
  • Hardie J. 1987. Oral submucous fibrosis. A review with case reports. J Can Dent Assoc. 53(5):389–393.
  • Hebert MF. 1997. Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery. Adv Drug Deliv Rev. 27(2–3):201–214.
  • Heck JE, Marcotte EL, Argos M, Parvez F, Ahmed A, Islam T, Sarwar G, Hasan R, Ahsan H, Chen Y. 2012. Betel quid chewing in rural Bangladesh: prevalence, predictors and relationship to blood pressure. Int J Epidemiol. 41(2):462–471.
  • Herbst ED, Harris DS, Everhart ET, Mendelson J, Jacob P, Jones RT. 2011. Cocaethylene formation following ethanol and cocaine administration by different routes. Exp Clin Psychopharmacol. 19(2):95–104.
  • Hoang S, Dao N, Myers AL. 2020. Electrophilic reactivity of the Busulfan metabolite, EdAG, towards cellular thiols and inhibition of human thioredoxin-1. Biochem Biophys Res Commun. 533(3):325–331.
  • Horenstein NA, Quadri M, Stokes C, Shoaib M, Papke RL. 2019. Cracking the betel nut: cholinergic activity of areca alkaloids and related compounds. Nicotine Tob Res. 21(6):805–812.
  • Hsieh TJ, Hsieh PC, Wu MT, Chang WC, Hsiao PJ, Lin KD, Chou PC, Shin SJ. 2011. Betel nut extract and arecoline block insulin signaling and lipid storage in 3T3-L1 adipocytes. Cell Biol Toxicol. 27(6):397–411.
  • Hsu HF, Tsou TC, Chao HR, Shy CG, Kuo YT, Tsai FY, Yeh SC, Ko YC. 2010. Effects of arecoline on adipogenesis, lipolysis, and glucose uptake of adipocytes-A possible role of betel-quid chewing in metabolic syndrome. Toxicol Appl Pharmacol. 245(3):370–377.
  • Hu CW, Chang YZ, Wang HW, Chao MR. 2010. High-throughput simultaneous analysis of five urinary metabolites of areca nut and tobacco alkaloids by isotope-dilution liquid chromatography-tandem mass spectrometry with on-line solid-phase extraction. Cancer Epidemiol Biomarkers Prev. 19(10):2570–2581.
  • Humans IWGotEoCRt. 2004. Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum. 85:1–334.
  • Hussain MA, Mollica JA. 1991. Intranasal absorption of physostigmine and arecoline. J Pharm Sci. 80(8):750–751.
  • IARC. 2004. Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum. 85:1–334.
  • IARC. 2021. Carcinogenicity of acrolein, crotonaldehyde, and arecoline. Lancet Oncol. 22(1):19–20.
  • Jain V, Garg A, Parascandola M, Chaturvedi P, Khariwala SS, Stepanov I. 2017. Analysis of alkaloids in areca nut-containing products by liquid chromatography-tandem mass spectrometry. J Agric Food Chem. 65(9):1977–1983.
  • Jeng JH, Chang MC, Hahn LJ. 2001. Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol. 37(6):477–492.
  • Jeng JH, Kuo ML, Hahn LJ, Kuo MY. 1994. Genotoxic and non-genotoxic effects of betel quid ingredients on oral mucosal fibroblasts in vitro. J Dent Res. 73(5):1043–1049.
  • Jeng JH, Tsai CL, Hahn LJ, Yang PJ, Kuo YS, Kuo MY. 1999. Arecoline cytotoxicity on human oral mucosal fibroblasts related to cellular thiol and esterase activities. Food Chem Toxicol. 37(7):751–756.
  • Jiang J, Chen X, Zhong D. 2018. Predominant contributions of carboxylesterase 1 and 2 in hydrolysis of anordrin in humans. Xenobiotica. 48(5):533–540.
  • Jokanovic M. 1989. Role of carboxylesterase in soman, sarin and tabun poisoning in rats. Pharmacol Toxicol. 65(3):181–184.
  • Kumar YC, Malviya M, Chandra JN, Sadashiva CT, Kumar CS, Prasad SB, Prasanna DS, Subhash MN, Rangappa KS. 2008. Effect of novel N-aryl sulfonamide substituted 3-morpholino arecoline derivatives as muscarinic receptor 1 agonists in Alzheimer’s dementia models. Bioorg Med Chem. 16(9):5157–5163.
  • Kuo TM, Luo SY, Chiang SL, Yeh KT, Hsu HT, Wu CT, Lu CY, Tsai MH, Chang JG, Ko YC. 2015. Fibrotic effects of arecoline N-oxide in oral potentially malignant disorders. J Agric Food Chem. 63(24):5787–5794.
  • Kuo TM, Nithiyanantham S, Lee CP, Hsu HT, Luo SY, Lin YZ, Yeh KT, Ko YC. 2019. Arecoline N-oxide regulates oral squamous cell carcinoma development through NOTCH1 and FAT1 expressions. J Cell Physiol. 234(8):13984–13993.
  • Laizure SC, Herring V, Hu Z, Witbrodt K, Parker RB. 2013. The role of human carboxylesterases in drug metabolism: have we overlooked their importance? Pharmacotherapy. 33(2):210–222.
  • Laizure SC, Hu ZY, Potter PM, Parker RB. 2020. Inhibition of carboxylesterase-1 alters clopidogrel metabolism and disposition. Xenobiotica. 50(3):245–251.
  • Laizure SC, Parker RB. 2020. Is genetic variability in carboxylesterase-1 and carboxylesterase-2 drug metabolism an important component of personalized medicine? Xenobiotica. 50(1):92–100.
  • Lee CH, Lee JM, Wu DC, Hsu HK, Kao EL, Huang HL, Wang TN, Huang MC, Wu MT. 2005. Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan. Int J Cancer. 113(3):475–482.
  • Lee HH, Chen LY, Wang HL, Chen BH. 2015. Quantification of salivary arecoline, arecaidine and N-methylnipecotic acid levels in volunteers by liquid chromatography-tandem mass spectrometry. J Anal Toxicol. 39(9):714–719.
  • Li B, Zhou XZ, Li JY, Yang YJ, Niu JR, Wei XJ, Liu XW, Li JS, Zhang JY. 2014. Determination and pharmacokinetic studies of arecoline in dog plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 969:12–18.
  • Lin CY, Pan TS, Ting CC, Liang SS, Huang SH, Liu HY, Ko EC, Wu CW, Tang JY, Chen PH. 2013. Cytochrome p450 metabolism of betel quid-derived compounds: implications for the development of prevention strategies for oral and pharyngeal cancers. ScientificWorldJournal. 2013:618032.
  • Lin KH, Lin CY, Liu CC, Chou MY, Lin JK. 2011. Arecoline N-oxide: its mutagenicity and possible role as ultimate carcinogen in areca oral carcinogenesis. J Agric Food Chem. 59(7):3420–3428.
  • Little MA, Papke RL. 2015. Betel, the orphan addiction. J Addict Res Ther. 6(3):e130.
  • Lopez-Vilchez MA, Seidel V, Farre M, Garcia-Algar O, Pichini S, Mur A. 2006. Areca-nut abuse and neonatal withdrawal syndrome. Pediatrics. 117(1):e129–e131.
  • Meghji S, Scutt A, Harvey W, Canniff JP. 1987. An in-vitro comparison of human fibroblasts from normal and oral submucous fibrosis tissue. Arch Oral Biol. 32(3):213–215.
  • Messiha HL, Munro AW, Bruce NC, Barsukov I, Scrutton NS. 2005. Reaction of morphinone reductase with 2-cyclohexen-1-one and 1-nitrocyclohexene: proton donation, ligand binding, and the role of residues Histidine 186 and Asparagine 189. J Biol Chem. 280(11):10695–10709.
  • Milgrom P, Tut OK, Gilmatam J, Gallen M, Chi DL. 2013. Areca use among adolescents in Yap and Pohnpei, the Federated States of Micronesia. Harm Reduct J. 10:26.
  • Miyazaki M, Sugawara E, Yoshimura T, Yamazaki H, Kamataki T. 2005. Mutagenic activation of betel quid-specific N-nitrosamines catalyzed by human cytochrome P450 coexpressed with NADPH-cytochrome P450 reductase in Salmonella typhimurium YG7108. Mutat Res. 581(1–2):165–171.
  • Myers AL, Kawedia JD, Champlin RE, Kramer MA, Nieto Y, Ghose R, Andersson BS. 2017. Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review. Expert Opin Drug Metab Toxicol. 13(9):901–923.
  • Nair J, Ohshima H, Friesen M, Croisy A, Bhide SV, Bartsch H. 1985. Tobacco-specific and betel nut-specific N-nitroso compounds: occurrence in saliva and urine of betel quid chewers and formation in vitro by nitrosation of betel quid. Carcinogenesis. 6(2):295–303.
  • Nair U, Bartsch H, Nair J. 2004. Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis. 19(4):251–262.
  • Ndikum-Moffor FM, Schoeb TR, Roberts SM. 1998. Liver toxicity from norcocaine nitroxide, an N-oxidative metabolite of cocaine. J Pharmacol Exp Ther. 284(1):413–419.
  • Nery R. 1971. The metabolic interconversion of arecoline and arecoline 1-oxide in the rat. Biochem J. 122(4):503–508.
  • Oakley E, Demaine L, Warnakulasuriya S. 2005. Areca (betel) nut chewing habit among high-school children in the Commonwealth of the Northern Mariana Islands (Micronesia). Bull World Health Organ. 83(9):656–660.
  • Ohshima H, Friesen M, Bartsch H. 1989. Identification in rats of N-nitrosonipecotic acid as a major urinary metabolite of the areca-nut alkaloid-derived nitrosamines, N-nitrosoguvacoline and N-nitrosoguvacine. Cancer Lett. 44(3):211–216.
  • Oliver AJ, Radden BG. 1992. Oral submucous fibrosis. Case report and review of the literature. Aust Dent J. 37(1):31–34.
  • Pan H, Li Y, Huang L, Zhou X, Lu Y, Shi F. 2018. Development and validation of a rapid LC-MS/MS method for simultaneous quantification of arecoline and its two active metabolites in rat plasma and its application to a pharmacokinetic study. J Pharm Biomed Anal. 154:397–403.
  • Panda S, Sharma R, Kar A. 2019. Chavibetol corrects thyrotoxicosis through alterations in thyroid peroxidase. Naunyn Schmiedebergs Arch Pharmacol. 392(5):541–550.
  • Papke RL, Horenstein NA, Stokes C. 2015. Nicotinic activity of arecoline, the psychoactive element of “betel nuts”, suggests a basis for habitual use and anti-inflammatory activity. PLoS One. 10(10):e0140907.
  • Parker RB, Hu ZY, Meibohm B, Laizure SC. 2015. Effects of alcohol on human carboxylesterase drug metabolism. Clin Pharmacokinet. 54(6):627–638.
  • Parker RB, Laizure SC. 2010. The effect of ethanol on oral cocaine pharmacokinetics reveals an unrecognized class of ethanol-mediated drug interactions. Drug Metab Dispos. 38(2):317–322.
  • Pasupuleti RR, Lee CH, Osborne PG, Wu MT, Ponnusamy VK. 2022. Rapid green analytical methodology for simultaneous biomonitoring of five toxic areca nut alkaloids using UHPLC-MS/MS for predicting health hazardous risks. J Hazard Mater. 422:126923.
  • Patidar KA, Parwani R, Wanjari SP, Patidar AP. 2015. Various terminologies associated with areca nut and tobacco chewing: a review. J Oral Maxillofac Pathol. 19(1):69–76.
  • Patrick KS, Corbin TR, Murphy CE. 2014. Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker. J Pharm Sci. 103(12):3834–3842.
  • Patrick KS, Straughn AB, Minhinnett RR, Yeatts SD, Herrin AE, DeVane CL, Malcolm R, Janis GC, Markowitz JS. 2007. Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther. 81(3):346–353.
  • Patterson TA, Kosh JW. 1993. Elucidation of the rapid in vivo metabolism of arecoline. Gen Pharmacol. 24(3):641–647.
  • Patterson TA, Kosh JW. 1994. Modification of the duration of action and pharmacodynamics of arecoline by tetraisopropylpyrophosphoramide. Pharmacol Res. 29(3):237–249.
  • Petti S, Warnakulasuriya S. 2018. Betel quid chewing among adult male immigrants from the Indian subcontinent to Italy. Oral Dis. 24(1-2):44–48.
  • Pichini S, Pellegrini M, Pacifici R, Marchei E, Murillo J, Puig C, Vall O, Garcia-Algar O. 2003. Quantification of arecoline (areca nut alkaloid) in neonatal biological matrices by high-performance liquid chromatography/electrospray quadrupole mass spectrometry. Rapid Commun Mass Spectrom. 17(17):1958–1964.
  • Pobutsky AM, Neri EI. 2012. Betel nut chewing in Hawai'i: is it becoming a public health problem? Historical and socio-cultural considerations. Hawaii J Med Public Health. 71(1):23–26.
  • Raffaele KC, Asthana S, Berardi A, Haxby JV, Morris PP, Schapiro MB, Soncrant TT. 1996. Differential response to the cholinergic agonist arecoline among different cognitive modalities in Alzheimer’s disease. Neuropsychopharmacology. 15(2):163–170.
  • Raffaele KC, Berardi A, Asthana S, Morris P, Haxby JV, Soncrant TT. 1991. Effects of long-term continuous infusion of the muscarinic cholinergic agonist arecoline on verbal memory in dementia of the Alzheimer type. Psychopharmacol Bull. 27(3):315–319.
  • Raffaele KC, Berardi A, Morris PP, Asthana S, Haxby JV, Schapiro MB, Rapoport SI, Soncrant TT. 1991. Effects of acute infusion of the muscarinic cholinergic agonist arecoline on verbal memory and visuo-spatial function in dementia of the Alzheimer type. Prog Neuropsychopharmacol Biol Psychiatry. 15(5):643–648.
  • Rajan G, Ramesh S, Sankaralingam S. 2007. Areca nut use in rural Tamil Nadu: a growing threat. Indian J Med Sci. 61(6):332–337.
  • Run-mei X, Jun-jun W, Jing-ya C, Li-juan S, Yong C. 2014. Effects of arecoline on hepatic cytochrome P450 activity and oxidative stress. J Toxicol Sci. 39(4):609–614.
  • Sahoo AK, Dandapat J, Dash UC, Kanhar S. 2018. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer’s disease. J Ethnopharmacol. 215:42–73.
  • Sattler M, Guengerich FP, Yun CH, Christians U, Sewing KF. 1992. Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. Drug Metab Dispos. 20(5):753–761.
  • Shakya B, Siddique YH. 2018. Evaluation of the toxic potential of arecoline toward the third instar larvae of transgenic Drosophila melanogaster (hsp70-lacZ) Bg9). Toxicol Res (Camb). 7(3):432–443.
  • Sharan RN, Mehrotra R, Choudhury Y, Asotra K. 2012. Association of betel nut with carcinogenesis: revisit with a clinical perspective. PLoS One. 7(8):e42759.
  • Shih YT, Chen PS, Wu CH, Tseng YT, Wu YC, Lo YC. 2010. Arecoline, a major alkaloid of the areca nut, causes neurotoxicity through enhancement of oxidative stress and suppression of the antioxidant protective system. Free Radic Biol Med. 49(10):1471–1479.
  • Singh A, Rao AR. 1993. Effects of arecoline on phase I and phase II drug metabolizing system enzymes, sulfhydryl content and lipid peroxidation in mouse liver. Biochem Mol Biol Int. 30(4):763–772.
  • Soncrant TT, Holloway HW, Greig NH, Rapoport SI. 1989. Regional brain metabolic responsivity to the muscarinic cholinergic agonist arecoline is similar in young and aged Fischer-344 rats. Brain Res. 487(2):255–266.
  • Stich HF, Rosin MP, Brunnemann KD. 1986. Oral lesions, genotoxicity and nitrosamines in betel quid chewers with no obvious increase in oral cancer risk. Cancer Lett. 31(1):15–25.
  • Sullivan RJ, Allen JS, Otto C, Tiobech J, Nero K. 2000. Effects of chewing betel nut (Areca catechu) on the symptoms of people with schizophrenia in Palau, Micronesia. Br J Psychiatry. 177:174–178.
  • Sun YP, Liu Q, Luo J, Guo P, Chen F, Lawrence AJ, Liang JH. 2010. Systemic administration of arecoline reduces ethanol-induced sleeping through activation of central muscarinic receptor in mice. Alcohol Clin Exp Res. 34(1):150–157.
  • Sundqvist K, Liu Y, Nair J, Bartsch H, Arvidson K, Grafstrom RC. 1989. Cytotoxic and genotoxic effects of areca nut-related compounds in cultured human buccal epithelial cells. Cancer Res. 49(19):5294–5298.
  • Thomsen R, Rasmussen HB, Linnet K, Consortium I, INDICES Consortium 2014. In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors. Drug Metab Dispos. 42(1):126–133.
  • Tsai JF, Chuang LY, Jeng JE, Ho MS, Hsieh MY, Lin ZY, Wang LY. 2001. Betel quid chewing as a risk factor for hepatocellular carcinoma: a case-control study. Br J Cancer. 84(5):709–713.
  • Tungare S, Myers AL. 2021. Retail availability and characteristics of addictive areca nut products in a US metropolis. J Psychoactive Drugs. 53(3):256–271.
  • Van der B, Van Eyk AD, Van Wyk CW, Stander IA. 2001. Diffusion of reduced arecoline and arecaidine through human vaginal and buccal mucosa. J Oral Pathol Med. 30(4):200–205.
  • Venkatesh D, Puranik RS, Vanaki SS, Puranik SR. 2018. Study of salivary arecoline in areca nut chewers. J Oral Maxillofac Pathol. 22(3):446.
  • Vilmer C, Civatte J. 1986. Oral submucous fibrosis. Review of the literature apropos of a case. Ann Dermatol Venereol. 113(2):107–112.
  • Voigt V, Laug L, Zebisch K, Thondorf I, Markwardt F, Brandsch M. 2013. Transport of the areca nut alkaloid arecaidine by the human proton-coupled amino acid transporter 1 (hPAT1). J Pharm Pharmacol. 65(4):582–590.
  • Vora AR, Yeoman CM, Hayter JP. 2000. Alcohol, tobacco and paan use and understanding of oral cancer risk among Asian males in Leicester. Br Dent J. 188(8):444–451.
  • Wang CK, Peng CH. 1996. The mutagenicities of alkaloids and N-nitrosoguvacoline from betel quid. Mutat Res. 360(3):165–171.
  • Wenke G, Brunnemann KD, Hoffmann D, Bhide SV. 1984. A study of betel quid carcinogenesis. IV. Analysis of the saliva of betel chewers: a preliminary report. J Cancer Res Clin Oncol. 108(1):110–113.
  • Wenke G, Hoffmann D. 1983. A study of betel quid carcinogenesis. 1. On the in vitro N-nitrosation of arecoline. Carcinogenesis. 4(2):169–172.
  • Wenke G, Rivenson A, Hoffmann D. 1984. A study of betel quid carcinogenesis. 3. 3-(Methylnitrosamino)-propionitrile, a powerful carcinogen in F344 rats. Carcinogenesis. 5(9):1137–1140.
  • Winstock A. 2002. Areca nut-abuse liability, dependence and public health. Addict Biol. 7(1):133–138.
  • Wood NH, Ayo-Yusuf OA, Gugushe TS, Bogers JP. 2019. Tobacco use and oral sex practice among dental clinic attendees. PLoS One. 14(3):e0213729.
  • Wu GH, Boucher BJ, Chiu YH, Liao CS, Chen TH. 2009. Impact of chewing betel-nut (Areca catechu) on liver cirrhosis and hepatocellular carcinoma: a population-based study from an area with a high prevalence of hepatitis B and C infections. Public Health Nutr. 12(1):129–135.
  • Wu IC, Chen PH, Wang CJ, Wu DC, Tsai SM, Chao MR, Chen BH, Lee HH, Lee CH, Ko YC. 2010. Quantification of blood betel quid alkaloids and urinary 8-hydroxydeoxyguanosine in humans and their association with betel chewing habits. J Anal Toxicol. 34(6):325–331.
  • Wu IC, Lu CY, Kuo FC, Tsai SM, Lee KW, Kuo WR, Cheng YJ, Kao EL, Yang MS, Ko YC. 2006. Interaction between cigarette, alcohol and betel nut use on esophageal cancer risk in Taiwan. Eur J Clin Invest. 36(4):236–241.
  • Xue J, Yang S, Seng S. 2014. Mechanisms of cancer induction by tobacco-specific NNK and NNN. Cancers (Basel). 6(2):1138–1156.
  • Zhou J, Sun Q, Yang Z, Zhang J. 2014. The hepatotoxicity and testicular toxicity induced by arecoline in mice and protective effects of vitamins C and e. Korean J Physiol Pharmacol. 18(2):143–148.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.